LIGAND PHARMACEUTICALS INC

Holdings History for Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (PTHS)

Symbol: PTHS on NYSE
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 5,189,177 shares
Security Ownership %: 50%

Ligand Pharmaceuticals Incorporated ownership in Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (PTHS)

10 Nov 2025 - Ligand Pharmaceuticals Incorporated has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,189,177 shares of Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (PTHS). This represents 50% ownership of the company. In their previous filing dated 03 Jul 2025, LIGAND PHARMACEUTICALS INC had reported owning 4,927,868 shares, indicating an increase of +5.3%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Ligand Pharmaceuticals Incorporated	50%	0%	$145,296,959	5,189,177	+261,309	+5.3%	$28.00	13D/A	06 Nov 2025	10 Nov 2025, 16:42
Ligand Pharmaceuticals Incorporated	50%			4,927,868			$25.30	13D	01 Jul 2025	03 Jul 2025, 16:05